孕期補充維生素 D3，可能影響孩子 10 年後的記憶力？

你懷孕時補充的營養，可能和孩子 10 年後的大腦表現有關？

一項隨機臨床試驗追蹤近 500 名兒童到 10 歲，研究發現：

孕期補充較高劑量維生素 D3，與孩子日後的語文記憶、視覺記憶表現有關。

視覺記憶差異甚至達 0.24 個標準差。

但這是否代表——
「孕婦多吃維生素 D，孩子就會更聰明？」

答案沒有這麼簡單。

點擊影片看懂最新研究、關鍵數據，以及孕期補充維生素 D3 真正需要注意的事。

孕期營養補充應依個人狀況與專業醫療建議進行，請勿自行服用超高劑量維生素 D。

#維生素D #孕期營養 #兒童發展 #記憶力 #孕婦健康 #科學實證 #健康素養 #AWAKE

Reference: High-Dose Vitamin D₃ Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A Post Hoc Secondary Analysis of a Randomized Clinical Trial

PI-Union Medical Science Ltd.

* E-mail: piunion@pi-union.com

* Website: https://pi-union.com/

* Facebook: www.facebook.com/piunion2020

* Youtube: www.youtube.com/@pi-union

* Instagram: www.instagram.com/piunion2020

* LINE: @654eukag

PI-Union Medical Science Ltd.

* E-mail: piunion@pi-union.com

* Official Website: https://pi-union.com/

* Facebook: www.facebook.com/piunion2020

* Youtube: www.youtube.com/@pi-union

* Instagram: www.instagram.com/piunion2020

* LINE: @654eukag

From the Democratization of Medical Knowledge to the Democratization of Medical Data

As large language models (LLMs) rapidly enter the healthcare sector, artificial intelligence is evolving beyond providing general health information and is beginning to interact directly with patients’ most sensitive personal health data.

A recent Viewpoint article in JAMA, “When Patients Share Everything With an AI Chatbot: Risks and Opportunities of Large Language Models,” examines the opportunities and challenges posed by a new generation of health-focused AI platforms such as ChatGPT Health. The authors argue that as patients gain the ability to synchronize their complete electronic health records (EHRs) with AI systems, healthcare is moving from the democratization of medical knowledge toward the democratization of medical data.

While this transformation has the potential to advance personalized medicine, it also raises unprecedented concerns regarding privacy, bias, and regulatory oversight.

What Is the Potential Value of AI Access to Complete Medical Records?

In theory, if AI systems can integrate patients’ medical histories, health monitoring data, wearable device information, and lifestyle records, they may provide several important benefits:

*More personalized health recommendations

*Earlier identification of rare diseases

*Enhanced epidemic and public health surveillance

*Greater utilization of Real-World Data (RWD)

*Accelerated clinical research and drug development

For researchers, large-scale and real-time integration of health data may become a critical foundation for the future of precision medicine.

Medical Records Are Not Entirely Objective

However, the authors highlight an important reality:

Electronic health records are not neutral repositories of facts.

In addition to objective laboratory and diagnostic findings, medical records often contain subjective assessments and interpretations made by healthcare professionals.

Examples include:

1. Behavioral descriptions of patients

2. Preliminary diagnostic impressions

3. Unconfirmed clinical assumptions

4. Potentially biased language or documentation

If AI systems learn directly from these records, they may reproduce—or even amplify—existing biases.

For example, a patient suffering from chronic pain may have previously been labeled as “drug-seeking.” Even if subsequent evaluations confirm a legitimate physiological cause for the pain, an AI system may still be influenced by earlier documentation and provide less appropriate recommendations.

In other words, AI systems may learn not only medical knowledge but also the biases embedded within healthcare systems.

AI May Reinforce Existing Health Disparities

The authors further note that healthcare systems already face significant health disparities.

Patients from different racial, ethnic, socioeconomic, and demographic backgrounds may experience unequal diagnosis and treatment.

If such disparities are reflected in EHR data and AI systems treat these records as objective truth, future applications may generate:

*Biased diagnoses

*Biased recommendations

*Biased risk assessments

As a result, existing healthcare inequities could become further entrenched.

Therefore, the risks associated with AI may stem not only from the model itself but also from the data used to train and inform it.

Can HIPAA Protect Patient Data Uploaded to AI Platforms?

Another key issue discussed in the article is data privacy.

Many patients assume that their medical information remains protected under the Health Insurance Portability and Accountability Act (HIPAA).

However, the authors point out that once patients voluntarily upload their medical records to a commercial AI platform, those data may no longer be fully protected under HIPAA.

The reason is that most AI platforms are not considered HIPAA-covered entities.

Consequently:

1. HIPAA restrictions on data use may not apply.

2. HIPAA security requirements may not apply.

3. HIPAA breach notification obligations may not apply.

Although AI companies may promise strong privacy protections, corporate privacy policies are fundamentally different from legally enforceable regulatory safeguards.

Lack of Transparency May Be the Greater Concern

According to the authors, the most significant challenge may not be data breaches, but rather the lack of transparency.

Currently, independent researchers have limited ability to evaluate:

*Whether AI systems exhibit bias against specific populations

*Whether safety incidents have occurred

*Whether inappropriate medical recommendations are being generated

*Whether AI is influencing patients’ healthcare-seeking behavior

Because these data remain under the control of platform developers, external validation is often impossible.

As a result, even when AI companies report strong performance, there may be insufficient independent evidence to verify such claims.

PI-Union Medical Science Commentary

Health-focused AI platforms such as ChatGPT Health represent an important milestone in the evolution of AI-powered healthcare. For the first time, patients may be able to provide AI systems with comprehensive health records for personalized analysis.

However, when AI begins reading entire medical records, it receives not only information about diseases and treatments but also decades of accumulated clinical assumptions, documentation biases, and systemic healthcare challenges.

For this reason, the future development of healthcare AI should not focus solely on technological innovation. Equal attention must be given to data governance, clinical evidence generation, regulatory oversight, and ongoing performance monitoring.

Only through robust safeguards can AI become a tool for improving healthcare outcomes rather than amplifying existing inequities and risks.

Reference: When Patients Share Everything With an AI Chatbot–Risks and Opportunities of Large Language Models

Reviewer: PI-Union Medical Science Ltd.

* E-mail: piunion@pi-union.com

* Official Website: https://pi-union.com/

* Facebook: www.facebook.com/piunion2020

* Youtube: www.youtube.com/@pi-union

* Instagram: www.instagram.com/piunion2020

* LINE: @654eukag

從醫療知識民主化到醫療資料民主化

隨著大型語言模型（Large Language Models, LLMs）快速進入醫療領域，人工智慧不再只是提供一般健康資訊，而開始直接接觸患者最敏感的個人健康資料。

近期刊登於《JAMA》的 Viewpoint 文章〈When Patients Share Everything With an AI Chatbot: Risks and Opportunities of Large Language Models〉，探討了新一代健康型 AI 平台（如 ChatGPT Health）所帶來的機會與挑戰。作者指出，當患者能夠將完整電子病歷（Electronic Health Records, EHRs）直接同步至 AI 系統時，我們正從「醫療知識的民主化」邁向「醫療資料的民主化」。

這項變革可能促進個人化醫療發展，但同時也引發前所未有的隱私、偏見與法規問題。

AI讀取完整病歷：潛在價值何在？

理論上，如果 AI 能夠整合患者的病歷資料、健康監測數據、穿戴裝置資訊以及生活型態紀錄，將可能帶來多項效益：

* 提供更個人化的健康建議

* 協助罕見疾病的早期辨識

* 強化流行病監測能力

* 促進真實世界資料（Real-World Data, RWD）的運用

* 加速臨床研究與藥物開發

對於研究人員而言，大規模且即時的健康資料整合，更有機會成為未來精準醫療（Precision Medicine）的重要基礎。

醫療紀錄並非完全客觀

然而，作者提醒我們一個重要事實：

「電子病歷不是中立的事實倉庫。」

病歷中的內容除了客觀檢驗數據外，也包含醫護人員的主觀判斷與描述。

例如：

1. 對患者的行為評價

2. 初步診斷推測

3. 尚未證實的臨床印象

4. 可能帶有偏見的文字紀錄

如果 AI 系統直接學習這些內容，可能會將既有偏見複製甚至放大。

例如某位慢性疼痛患者曾被標註為「疑似尋求藥物（drug-seeking）」，即使後續證實其疼痛有明確生理原因，AI 仍可能受到早期紀錄影響，而提供較不適當的建議。

換言之，AI 不只是學習醫學知識，也可能學習醫療體系中的偏見。

AI可能複製醫療不平等

作者進一步指出，醫療體系本身就存在健康不平等（Health Disparities）問題。

不同種族、性別、社經背景的患者，在診斷與治療過程中可能面臨不同待遇。

若這些偏差已存在於電子病歷中，而 AI 又將其視為「真實資料」進行學習，未來可能形成：

* 偏差診斷（Biased Diagnosis）

* 偏差建議（Biased Recommendations）

* 偏差風險評估（Biased Risk Assessment）

最終使既有醫療不平等被進一步強化。

因此，AI 的風險不一定來自模型本身，而可能來自模型所學習的資料。

HIPAA保護不了患者主動上傳的資料？

文章另一項值得關注的議題是資料隱私。

許多患者認為醫療資料受到 HIPAA（Health Insurance Portability and Accountability Act）保護，因此相當安全。

然而作者指出：

當患者自行將病歷上傳至商業化 AI 平台後，這些資料未必仍受到 HIPAA 的完整保障。

原因在於：

AI 平台通常不是 HIPAA 所定義的醫療照護提供者（Covered Entity）。

因此：

1. HIPAA 的資料使用限制可能不適用

2. HIPAA 的資訊安全規範可能不適用

3. HIPAA 的資料外洩通報義務可能不適用

雖然企業可能承諾保護使用者隱私，但企業政策與法律保障仍有本質上的差異。

缺乏透明度是更大的問題

作者認為，目前最大的隱憂或許不是資料外洩，而是缺乏透明度。

目前外界難以得知：

* AI 是否對特定族群產生偏見

* 是否曾發生安全事件

* 是否提供不當醫療建議

* 是否影響患者就醫行為

由於相關資料掌握在平台開發者手中，獨立研究人員往往無法進行驗證。

因此，即使 AI 系統宣稱具有良好效能，也缺乏足夠的第三方證據支持。

百聯醫學評論

ChatGPT Health 類型的產品代表醫療 AI 發展的重要里程碑，也讓患者首次有機會將自己的完整健康資料交由 AI 分析。

然而，當 AI 開始閱讀完整病歷時，它接收到的不只是疾病資訊，也包括醫療體系長期累積的偏見、誤判與制度性問題。

因此，未來醫療 AI 的發展不應只關注技術創新，更需要建立完善的資料管理、臨床證據與法規監管機制，才能真正讓 AI 成為改善健康照護的工具，而非放大既有問題的新風險來源。

Reference: When Patients Share Everything With an AI Chatbot–Risks and Opportunities of Large Language Models

Reviewer: PI-Union Medical Science Ltd.

* E-mail: piunion@pi-union.com

* Official Website: https://pi-union.com/

* Facebook: www.facebook.com/piunion2020

* Youtube: www.youtube.com/@pi-union

* Instagram: www.instagram.com/piunion2020

* LINE: @654eukag

梁可憲(Ke-Hsien Liang)；王智弘(Chih-Hung Wang)

《幼兒教保研究》 21期 (2019/01) Pp. 39-57

The research is based on Spiritual Science, also known as Anthroposophy, which was founded by R. Steiner, to interpret the law of karma and essence of spiritual life of human being. The picture of early-childhood education in the light of Anthroposophy involves the source of life, stages of development, and the purpose of education. 

The conclusions are: 

1. Life is for the development of the spirit itself. 

2. Every child has his/her own unique and individual spirit and purpose. 

3. Educators must see the spiritual life picture holistically, including karmic conditions. 

4. Children imitate everything around them and set their body foundation which will make their future health and creativity possibly developed. Therefore, good simple life and life rhythm are essential in early childhood. Facing the crisis on materialism and modernity, Spiritual Science might inspire a new paradigm of early-childhood education.

Commentary: The Role and Challenges of Spiritual Education in Early Childhood Development

Liang Ke-Hsien and Wang Chih-Hung’s article, “The Essence and Development of Early Childhood Life from Rudolf Steiner’s Perspective of Spiritual Science,” published in Issue 21 of Early Childhood Education Research, is a rare and thought-provoking study that examines the essence of early childhood education through the lens of spiritual philosophy. Grounded in Rudolf Steiner’s Anthroposophy and spiritual science, the article explores the spiritual nature of young children, concepts of karma, and the process of human becoming, while further discussing their implications for contemporary educational practice.

Spiritual Development as the Purpose of Life: A Return to Educational Philosophy?

One of the paper’s most inspiring propositions is the idea that “spiritual development itself is the ultimate purpose of life,” transcending the utilitarian orientation of mainstream education that emphasizes competence, performance, or social adaptation. Such a perspective challenges today’s highly institutionalized and standardized early childhood education systems, prompting us to ask: Has education forgotten that children are spiritual beings rather than merely social instruments to be shaped?

Furthermore, the authors argue that every child enters this life with an individual mission and karmic background, and therefore should be educated with respect for their individuality and soul journey. This notion resonates with contemporary Western educational psychology concepts such as “strengths-based learning” and “personalized learning,” yet adds a deeper philosophical and spiritual dimension.

The Transformation of the Teacher’s Role: From Knowledge Transmitter to Karmic Companion

The article’s educational implications place strong emphasis on the idea that educators should learn to perceive the karmic consequences and spiritual signs present within each child. This perspective raises the expectations of teacher professionalism to a remarkably high level—not only requiring pedagogical competence, but also the capacity to understand human nature and spiritual development.

Although this viewpoint is intellectually and spiritually inspiring, its feasibility within existing educational systems and teacher-training institutions remains open to debate and further examination.

Imitation and Role Modeling: How a Benevolent Worldview Shapes Character

Steiner-inspired education emphasizes the belief that “the world is good” as a foundational assumption in early childhood education. This premise provides an important basis for children’s imitative learning. The authors point out that imitation is not merely behavioral copying, but a process of projecting and internalizing spiritual forces.

In contemporary educational theories that stress social imitation and role learning, this paper offers a deeper interpretive framework. It also calls upon teachers themselves to become moral exemplars whose character and conduct subtly influence the spiritual growth of children.

Critique and Reflection: Bridging Science and Spirituality

Nevertheless, the article raises several important questions worthy of reflection:

• The boundaries of spiritual language in education:
  Within the context of Anthroposophy, concepts such as “past lives,” “karma,” and “spiritual mission” may appear overly esoteric to some educators and parents. A major challenge lies in translating these profound philosophical ideas into practical and actionable teaching methods.
• Integration with positivist educational paradigms:
  Modern education systems tend to emphasize empirical approaches such as behavioral observation, developmental assessment, and cognitive theory. How spiritually oriented educational perspectives can be understood and accepted within such frameworks requires further dialogue and evidence-based practice.
• The possibility of cultural localization:
  Steiner’s philosophy originated within the cultural context of early twentieth-century Germany. Although the authors attempt to reinterpret his educational ideas for contemporary readers, the practicality of implementing these concepts within Taiwanese society remains uncertain—especially amid the tensions between diverse belief systems and secular educational institutions.

Conclusion: Repositioning Spiritual Education

Liang and Wang’s article introduces into Taiwanese academia an educational dimension that has long been overlooked: the growth and dignity of spiritual life. At a time when global education is increasingly driven by technology and performance metrics, revisiting the spiritual foundations of education encourages us to reconsider the fundamental question: What is education for?

The article ultimately reminds us that education is not merely the transmission of knowledge, but an encounter and cultivation between souls.

Looking forward, if Anthroposophical spirituality could be integrated with modern educational technologies and methodologies, it may be possible to develop a cross-disciplinary and cross-belief “new model of spiritual education” that opens a new horizon for contemporary early childhood education.

Translator and Reviewer: PI-Union Medical Science Ltd.

Source: R. Steiner靈性科學觀點下幼兒生命的本質與發展

為善最樂，請支持兒童公益社福機構:

聯合國兒童基金會 UNICEF

台灣世界展望會

家扶基金會

無國界醫生

A Review and Commentary on the Emerging Era of Cancer Vaccines

摘要

近年來，隨著疫苗科技與腫瘤免疫學的快速發展，癌症疫苗再度成為全球醫學研究的焦點。2023 年英國啟動的 Cancer Vaccine Advance 計畫，旨在於 2030 年前為 1 萬名癌症患者提供個人化 mRNA 癌症疫苗接種，象徵癌症疫苗從概念驗證邁向大規模臨床應用的重要里程碑。本文綜述癌症疫苗的發展歷程、最新技術突破與臨床證據，並分析人工智慧、基因體醫學與疫苗平台技術如何重塑癌症免疫治療。同時，本文結合全球政策與科研投資趨勢，探討癌症疫苗在未來公共衛生與精準醫療中的戰略意義。

一、癌症疫苗：從理論概念到臨床轉折

疫苗長期以來主要被視為預防傳染病的公共衛生工具，其基本原理是透過刺激免疫系統，使人體在病原體感染前即具備防禦能力。然而，癌症疫苗的設計理念與傳統疫苗有所不同，其目標不僅在於預防癌症發生，也可作為治療工具，促使免疫系統辨識並清除腫瘤細胞。

癌症疫苗大致可分為兩類：

1. 預防性疫苗（preventive vaccines）
2. 治療性疫苗（therapeutic vaccines）

目前臨床上已證實具有顯著公共衛生效益的主要為預防性疫苗，例如：

• B型肝炎疫苗（預防肝癌）
• 人類乳突病毒疫苗（預防子宮頸癌）

相比之下，治療性癌症疫苗的發展較為緩慢。截至目前為止，僅有少數獲得監管機構批准：

• BCG (Bacillus Calmette–Guérin) （用於膀胱癌，屬於活性減毒細菌免疫療法）
• talimogene laherparepvec（用於黑色素瘤，屬於溶瘤病毒治療）
• sipuleucel-T（用於前列腺癌，屬於自體樹突細胞疫苗）

然而，這些療法在臨床應用上仍受到療效幅度、製程複雜性與成本等因素限制。

二、COVID-19 疫情：癌症疫苗發展的意外催化劑

2020 年以後，COVID-19 疫苗的成功改變了全球疫苗科技的發展軌跡。mRNA 疫苗平台的快速研發與大規模生產，使得原本需要數十年的疫苗開發週期大幅縮短。

疫情期間建立的關鍵基礎設施包括：

• mRNA 疫苗製造技術
• 全球冷鏈物流系統
• 即時基因體監測
• 大規模臨床試驗平台
• 跨國政府與產業合作模式

這些基礎設施在疫情後迅速被轉化為其他醫療領域的研發能力，其中最受關注的便是癌症疫苗。

英國在 2023 年啟動的 Cancer Vaccine Advance 計畫 即是一個代表性案例。該計畫結合政府、學界與產業資源，透過跨腫瘤類型的大型臨床試驗，評估個人化 mRNA 癌症疫苗的安全性與療效。

這種國家級戰略顯示，癌症疫苗已從單純的學術研究議題，逐漸上升為國家醫療與生物科技競爭力的重要指標。

三、技術突破：個人化癌症疫苗與新抗原革命

癌症疫苗研究的最大突破來自於新抗原（neoantigen）疫苗的出現。

腫瘤細胞在基因突變過程中會產生特定的蛋白質變異，這些變異抗原只存在於腫瘤細胞，而不存在於正常組織，因此成為理想的免疫治療標靶。

透過次世代定序與生物資訊分析，研究人員可以：

1. 解析患者腫瘤的突變圖譜
2. 預測具有免疫原性的抗原
3. 設計個人化疫苗

mRNA 疫苗平台則提供了快速製造與高度客製化的能力。

在一項第二期臨床試驗中，個人化 mRNA 新抗原疫苗 mRNA-4157 與免疫檢查點抑制劑(immune checkpoint inhibitor) pembrolizumab 聯合治療黑色素瘤患者，顯示復發率明顯下降，無復發存活率(Recurrence-Free Survival)達 79%，顯示個人化疫苗具有實際臨床潛力。

此外，另一類研究方向是共享抗原疫苗（shared antigen vaccines），例如針對 HER2（ERBB2）等腫瘤驅動基因的疫苗，亦在多項臨床試驗中展現長期免疫反應。

四、人工智慧與癌症疫苗設計

癌症疫苗最大的挑戰之一是抗原選擇。
腫瘤具有高度異質性，且許多腫瘤屬於「免疫冷腫瘤」（immune cold tumor），也就是腫瘤微環境中幾乎沒有免疫細胞（尤其是 T 細胞）浸潤的腫瘤，免疫細胞難以進入腫瘤微環境。

人工智慧與高效能計算正在改變這一局面。透過訓練生成式 AI 模型，研究人員可以預測最具免疫原性的抗原組合，並設計多抗原疫苗。

英國的 Cancer Vaccines AI & Supercomputer Project 即利用真實腫瘤資料訓練 AI，以加速疫苗靶點的發現與設計。這類技術可能大幅縮短疫苗開發時間，並提高治療精準度。

五、全球科技競爭與政策意涵

從全球科研格局來看，美國仍是癌症疫苗研究的主要領導者，約佔全球相關論文的一半。然而，近期美國對疫苗與相關科技的研究資金出現縮減趨勢，可能影響未來創新能力。

相對而言，歐洲與英國正積極將疫情期間建立的生物科技能力轉向癌症研究，並透過國家級計畫加速臨床應用。

癌症疫苗市場亦呈現快速成長：

• 2023 年：約 101 億美元
• 2032 年預估：425 億美元

這意味著癌症疫苗不僅是醫學突破，也將成為全球生物醫藥產業的重要競爭領域。

六、未來方向：從治療走向預防

癌症疫苗策略正在發生重要轉變。過去多數研究集中於晚期腫瘤治療，但新的研究顯示，在微小殘留疾病（minimal residual disease, MRD）階段接種疫苗，可能更有效預防癌症復發。

未來癌症疫苗的應用可能包括：

• 術後預防復發
• 癌前病變免疫預防
• 高風險族群預防性疫苗

這種模式將使癌症疫苗逐漸融入公共衛生與預防醫學體系。

結論

癌症疫苗的發展歷經數十年的探索，雖然早期成果有限，但隨著 mRNA 技術、基因體醫學與人工智慧的進步，該領域正迎來關鍵轉折點。英國 Cancer Vaccine Advance 計畫與全球多項臨床試驗顯示，癌症疫苗已從概念研究逐漸邁向實際醫療應用。

在癌症發生率持續上升的背景下，癌症疫苗不僅可能改變腫瘤治療模式，也有潛力成為預防癌症的重要公共衛生工具。未來若能持續投入科研資源、整合人工智慧與精準醫療技術，癌症疫苗有望成為下一個改變醫學歷史的重大突破。

Reference: The Time for Cancer Vaccines Is Now Advancing Toward Lasting Cancer Immunity

English version: Key Turning Points in Cancer Vaccines: Rethinking the Global Strategy from Technological Breakthroughs to Strategic Implementation

Reviewer: PI-Union Medical Science Ltd.

• E-mail: piunion@pi-union.com
• Official Website: https://pi-union.com/
• Facebook: www.facebook.com/piunion2020
• Youtube: www.youtube.com/@pi-union
• Instagram: www.instagram.com/piunion2020
• LINE: @654eukag

Liucan Xu, et al. Clinical Psychology Review. Volume 123, February 2026, 102693

1. 研究背景

第二代正念介入（second-generation mindfulness-based interventions, SG-MBIs）在傳統正念介入的基礎上，明確整合倫理與慈悲相關的實踐，近年被視為在改善憂鬱與焦慮症狀方面具有潛力的心理介入模式。相較於僅聚焦於注意力與當下覺察的第一代正念介入，SG-MBIs 強調以倫理導向與慈悲動機來引導正念的運用，以促進更全面的情緒調節與心理健康。

本研究旨在透過系統性回顧與統合分析，評估 SG-MBIs 在減少成人憂鬱與焦慮症狀方面的整體效果，並進一步檢視影響介入成效的潛在調節因素。

2. 方法

研究設計
本研究納入隨機對照試驗（randomized controlled trials, RCTs），研究對象為成人樣本，包括臨床族群、健康成人，以及具有心理困擾或身體疾病但未正式診斷之混合族群。

資料來源
系統性搜尋 PubMed、Web of Science 與 EBSCOhost 資料庫，檢索截至 2025 年 4 月發表之相關研究。

效應大小計算
採用 Hedges’ g 作為效應大小指標，比較介入組與對照組在介入後憂鬱與焦慮症狀的差異，並使用隨機效應模型進行統合分析。

3. 主要發現

• SG-MBIs 能顯著降低成人的憂鬱症狀（g = 0.59）與焦慮症狀（g = 0.61）。
• 介入效果在臨床族群中最為顯著，且以自我慈悲為核心的介入方案呈現較佳成效。
• 憂鬱症狀的改善在追蹤期間仍可維持，而焦慮症狀的長期效果相對不穩定。
• 受試者類型與介入類型為顯著調節因子，其餘調節變項（如控制組型態、介入時長與偏誤風險）未達顯著。

4. 討論

本研究結果顯示，SG-MBIs 在減少憂鬱與焦慮症狀方面具備穩健效果，特別適用於臨床族群與以自我慈悲為核心的介入模式。相較於僅強調注意力訓練的正念介入，SG-MBIs 可能透過培養自我關係的溫和態度與倫理導向的心理調節機制，帶來更深層的情緒改善。

然而，現有 SG-MBIs 多以倫理與慈悲成分為主，對智慧（wisdom, prajñā）層面的直接訓練仍相對不足。未來研究有必要發展更清晰的操作型定義、標準化的介入架構，並進一步探索不同正念世代在心理治療中的角色與分工。

5. 限制

• 多數納入研究被評為「有一些擔憂」的偏誤風險，顯示研究品質仍有提升空間。
• 然而，在排除高偏誤風險研究後，主要結果仍維持一致，支持本研究結論的穩定性。

結論

整體而言，第二代正念介入在降低成人憂鬱與焦慮症狀方面具有顯著效果。未來研究應進一步釐清倫理與慈悲成分的關鍵作用機制，並探索智慧導向正念介入的臨床潛力，以促進更全面且具文化深度的正念治療模式。

二、第一代正念（FG-MBIs） vs 第二代正念（SG-MBIs）的差異

面向	第一代正念（FG-MBIs）	第二代正念（SG-MBIs）
代表介入	MBSR、MBCT	MSC、CCT、CBCT、MAT、MBPBS、MBPP
理論核心	正念作為注意力與覺察技術	正念作為具倫理導向的修習
三學架構定位	以「定（samādhi）」為主	「戒（sīla）＋定（samādhi）」
核心成分	當下覺察、非評價接受	慈悲、自我慈悲、倫理反思
是否納入空性／智慧		（屬於第三代）
主要治療目標	壓力與情緒調節	情緒調節＋自我關係修復
心理作用機制	去中心化、減少反芻	降低羞愧、自責，提升安全感
應用重點	焦慮、壓力、復發預防	臨床憂鬱、焦慮、心理脆弱族群

空性、無我、非二元等智慧導向實踐，依現行文獻分類，屬於第三代正念介入（TG-MBIs）

Review of

“The Effectiveness of Second-Generation Mindfulness Interventions on Anxiety and Depression: A Systematic Review and Meta-Analysis”

This systematic review and meta-analysis by Xu et al. offers a timely and methodologically rigorous synthesis of the evidence on second-generation mindfulness-based interventions (SG-MBIs) for anxiety and depression in adults. By focusing on interventions that explicitly integrate ethical and moral dimensions alongside attentional mindfulness practices, the authors address an important and underexplored development in the mindfulness literature.

A major strength of this study lies in its comprehensive scope and adherence to high methodological standards. The inclusion of randomized controlled trials across clinical, non-clinical, and mixed adult populations strengthens the robustness and generalizability of the findings. The meta-analytic results demonstrate moderate and statistically significant reductions in depressive (g = 0.59) and anxiety symptoms (g = 0.61), with particularly strong effects observed in clinical samples. These findings provide compelling evidence that SG-MBIs constitute a clinically meaningful extension of first-generation mindfulness-based interventions.

The moderator analyses further enhance the contribution of this review. By identifying participant type and intervention type as significant moderators, the study highlights that SG-MBIs are not uniformly effective across populations or formats. In particular, the stronger effects associated with self-compassion–focused interventions suggest that targeting self-related processes—such as shame, self-criticism, and emotional safety—may be a key mechanism underlying symptom improvement. Moreover, the finding that reductions in depressive symptoms were sustained at follow-up underscores the potential durability of SG-MBIs, even though long-term effects on anxiety appear less stable.

Despite these strengths, several conceptual and methodological issues warrant closer consideration. First, although the authors define SG-MBIs as interventions integrating ethical and moral practices, the operationalization of these components varies substantially across included studies. Programs such as Mindful Self-Compassion, Compassion Cultivation Training, and Cognitively-Based Compassion Training differ in theoretical emphasis, pedagogical structure, and practice intensity. Treating these interventions as a relatively homogeneous category may obscure meaningful differences in underlying mechanisms and limits interpretability of the pooled estimates.

Second, while the study reports that many potential moderators (e.g., control condition, intervention duration, outcome measure, and risk of bias status) were not statistically significant, these null findings are not fully theorized. For example, the lack of a dose–response relationship may suggest that SG-MBIs operate through qualitative shifts in self–emotion relations rather than through incremental practice time alone. Greater engagement with theoretical models of compassion-based and ethics-oriented regulation could strengthen interpretation of these results.

Third, the authors appropriately note the need to explore wisdom-based practices in future research, but this recommendation would benefit from clearer conceptual boundaries. Within emerging frameworks that distinguish first-, second-, and third-generation mindfulness-based interventions, wisdom-oriented practices (e.g., insight into non-attachment, emptiness, or non-duality) are increasingly viewed as conceptually distinct from ethics- and compassion-based training. Explicitly situating SG-MBIs within this broader generational and theoretical landscape would help clarify what SG-MBIs currently achieve—and what remains beyond their scope.

Finally, although most included trials were rated as having “some concerns” regarding risk of bias, the authors’ sensitivity analyses suggest that the main findings are robust. Nonetheless, the overall quality of evidence underscores the need for more rigorously designed and adequately powered randomized controlled trials, as well as clearer reporting standards and standardized intervention protocols.

In conclusion, this meta-analysis makes a valuable contribution to the mindfulness and mental health literature by demonstrating that SG-MBIs are effective in reducing depression and anxiety, particularly among clinical populations. By foregrounding ethical and compassion-based dimensions of mindfulness practice, the study advances understanding beyond attentional models alone. Future research would benefit from sharper conceptual definitions, theoretically informed moderator analyses, and systematic investigation of how ethics-based and wisdom-based components differentially contribute to psychological change. As such, this review provides a solid empirical foundation while also pointing toward important directions for the next phase of mindfulness intervention research.

Source: The effectiveness of second-generation mindfulness interventions on anxiety and depression: A systematic review and meta-analysis

Translator and Reviewer: PI-Union Medical Science Ltd.

• E-mail: piunion@pi-union.com
• Official Website: https://pi-union.com/
• Facebook: www.facebook.com/piunion2020
• Youtube: www.youtube.com/@pi-union
• Instagram: www.instagram.com/piunion2020
• LINE: @654eukag

醫學研究的誠信與品質，建立在嚴謹的倫理標準之上。國際醫學期刊編輯委員會（ICMJE）於 2026 年 1 月 正式發布了最新版的《醫藥期刊學術工作實施、報告、編輯與出版建議》（Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals）。

為了協助研究者與醫護同仁接軌國際最新標準，百聯醫學編譯特此整理四大核心變革與規範重點：

一、 作者身分（Authorship）的四項必備標準

根據最新規範，名列作者必須同時滿足以下四項條件，缺一不可：

1. 實質性貢獻：對研究的構思、設計，或數據的取得、分析與詮釋有重大貢獻。
2. 關鍵性起草與修訂：參與文章草擬，或對其中重要的知識內容進行關鍵性修改。
3. 最終版本核准：確認並核准即將出版的文章版本。
4. 誠信責任承擔：同意對研究的所有面向負責，確保任何關於準確性或誠信的問題都能得到妥善調查與解決。

特別注意：僅提供經費支持、行政管理或單純語言編修（如翻譯）的人員，不符合作者資格，應列於「誌謝（Acknowledgments）」中。

二、 人工智慧（AI）輔助技術的應用規範

針對生成式 AI（如 ChatGPT、LLM）的普及，2026 年新版規範建立了明確紅線：

• 嚴禁列為作者：AI 軟體不具備法律實體身分，無法承擔研究責任，嚴禁列為作者。
• 透明揭露義務：
  • 寫作輔助：若使用 AI 進行語言潤飾或校對，須在誌謝區說明。
  • 研究執行：若 AI 用於數據收集、分析或圖像生成，必須在 <方法論(Methods)> 中詳細描述其工具名稱、版本及應用方式。
• 人類作者責任：所有 AI 生成內容的準確性、真實性及有無剽竊現象，均由人類作者負最終責任。

三、 研究誠信與利益衝突（Conflicts of Interest）

• 全方位揭露：作者必須透明揭露與研究相關的所有財務關係（如顧問費、專利權、股票持份）及潛在的競爭利益。
• 數據存取權：作者必須保證能完全存取原始數據，不得簽署任何限制數據獨立分析或發布權力的合約。
• 學術不端處理：對於數據造假、圖片非法竄改等行為，期刊將嚴格執行撤稿（Retraction）程序。

四、 出版倫理與同儕審查

• 臨床試驗註冊：所有臨床試驗必須在招募第一位受試者前，於公開資料庫（如 ClinicalTrials.gov）完成註冊。
• 重複投稿限制：嚴禁將同一份稿件同時投稿至多個期刊（Simultaneous Submission）。
• 防範掠奪性期刊：作者有義務審慎評估投稿對象，避免將研究成果發表於缺乏品質控管的掠奪性期刊中。

結語: ICMJE 規範的更新反映了醫學界對學術誠信的最高要求。掌握這些標準，不僅是順利發表 SCI/SSCI 論文的關鍵，更是確保研究價值能被國際認可的基石。

Source: International Committee of Medical Journal Editors (ICMJE) – Recommendations 2026.

Translator: PI-Union Medical Science Ltd.

• E-mail: piunion@pi-union.com
• Official Website: https://pi-union.com/
• Facebook: www.facebook.com/piunion2020
• Youtube: www.youtube.com/@pi-union
• Instagram: www.instagram.com/piunion2020
• LINE: @654eukag